{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:10:45Z","timestamp":1791641445629,"version":"4.3.4"},"reference-count":144,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T00:00:00Z","timestamp":1478044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jacc.2016.08.079","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T19:15:57Z","timestamp":1482174957000},"page":"2871-2886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":308,"title":["Clinical and Mechanistic Insights Into the\u00a0Genetics of Cardiomyopathy"],"prefix":"10.1016","volume":"68","author":[{"given":"Michael A.","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Seidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Seidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2016.08.079_bib1","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Contemporary definitions and classification of the cardiomyopathies","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2016.08.079_bib3","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJM198911163212005","article-title":"Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1","volume":"321","author":"Jarcho","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2016.08.079_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples","author":"Walsh","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCGENETICS.111.961805","article-title":"Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era","volume":"5","author":"Norton","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib8","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/CIRCGENETICS.112.963421","article-title":"Cardiac structural and sarcomere genes associated with cardiomyopathy exhibit marked intolerance of genetic variation","volume":"5","author":"Pan","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib9","first-page":"1180","article-title":"Independent origin of identical beta cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy","volume":"53","author":"Watkins","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib10","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib11","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.92.7.1680","article-title":"Hypertrophic cardiomyopathy. Clinical spectrum and treatment","volume":"92","author":"Wigle","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib12","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.jacc.2006.07.065","article-title":"Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy","volume":"48","author":"Nagueh","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2003.05.009","article-title":"Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults","volume":"116","author":"Zou","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib15","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1161\/CIRCULATIONAHA.105.593558","article-title":"Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study","volume":"113","author":"Morita","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ajhg.2012.07.017","article-title":"Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts","volume":"91","author":"Bick","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/CIRCGENETICS.112.962928","article-title":"Population-based variation in cardiomyopathy genes","volume":"5","author":"Golbus","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","article-title":"A\u00a0molecular basis for familial hypertrophic cardiomyopathy: a \u03b2 cardiac myosin heavy chain gene missense mutation","volume":"62","author":"Geisterfer-Lowrance","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2016.08.079_bib19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0092-8674(90)90273-H","article-title":"A\u00a0molecular basis for familial hypertrophic cardiomyopathy: an \u03b1\/\u03b2 cardiac myosin heavy chain hybrid gene","volume":"62","author":"Tanigawa","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2016.08.079_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0092-8674(94)90054-X","article-title":"\u03b1-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere","volume":"77","author":"Thierfelder","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2016.08.079_bib21","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM199504203321603","article-title":"Mutations in the genes for cardiac troponin T and \u03b1-tropomyosin in hypertrophic cardiomyopathy","volume":"332","author":"Watkins","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng1295-438","article-title":"Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy","volume":"11","author":"Bonne","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ng1295-434","article-title":"Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy","volume":"11","author":"Watkins","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ng0596-63","article-title":"Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle","volume":"13","author":"Poetter","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng0897-379","article-title":"Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy","volume":"16","author":"Kimura","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib26","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1172\/JCI6460","article-title":"\u03b1-Cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy","volume":"103","author":"Mogensen","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2016.08.079_bib27","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1006\/jmcc.2000.1204","article-title":"Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy","volume":"32","author":"Olson","year":"2000","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib28","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/humu.20862","article-title":"Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives","volume":"30","author":"Andersen","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacc.2016.08.079_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejmg.2010.07.007","article-title":"Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy","volume":"53","author":"Millat","year":"2010","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/AC.67.1.2146562","article-title":"Spectrum and clinical manifestations of mutations in genes responsible for hypertrophic cardiomyopathy","volume":"67","author":"Curila","year":"2012","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.repc.2011.12.020","article-title":"Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population","volume":"31","author":"Brito","year":"2012","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.amjcard.2013.04.021","article-title":"Mutation spectrum in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy","volume":"112","author":"Liu","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib34","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0025-6196(11)61527-9","article-title":"Yield of genetic testing in hypertrophic cardiomyopathy","volume":"80","author":"Van Driest","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2016.08.079_bib35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib36","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0735-1097(93)90055-6","article-title":"Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene","volume":"22","author":"Solomon","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4065\/81.4.459","article-title":"Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations","volume":"81","author":"Binder","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2016.08.079_bib38","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.RES.0000263008.66799.aa","article-title":"Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy","volume":"100","author":"Osio","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2016.08.079_bib39","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jacc.2009.11.016","article-title":"Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis","volume":"55","author":"Chiu","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/bbrc.1999.1221","article-title":"Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene","volume":"262","author":"Satoh","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacc.2016.08.079_bib41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ymgme.2005.10.008","article-title":"Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin","volume":"88","author":"Bos","year":"2006","journal-title":"Mol Genet Metabl"},{"key":"10.1016\/j.jacc.2016.08.079_bib42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of titin causing dilated cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib43","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0092-8674(02)01226-6","article-title":"The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy","volume":"111","author":"Kn\u00f6ll","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2016.08.079_bib44","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1093\/hmg\/ddn160","article-title":"Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy","volume":"17","author":"Geier","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib45","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.0000056522.82563.5F","article-title":"Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy","volume":"107","author":"Geier","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib46","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.bpj.2014.02.011","article-title":"Hypertrophic and dilated cardiomyopathy: four decades of basic research on muscle lead to potential therapeutic approaches to these devastating genetic diseases","volume":"106","author":"Spudich","year":"2014","journal-title":"Biophys J"},{"key":"10.1016\/j.jacc.2016.08.079_bib47","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A\u00a0small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jacc.2016.08.079_bib48","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/CIRCRESAHA.110.231670","article-title":"In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament","volume":"108","author":"Harris","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2016.08.079_bib49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCRESAHA.109.202440","article-title":"Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency","volume":"105","author":"Marston","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2016.08.079_bib50","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","article-title":"Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction","volume":"119","author":"van Dijk","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib51","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yjmcc.2014.11.018","article-title":"Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice","volume":"79","author":"Barefield","year":"2015","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib52","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.RES.86.7.737","article-title":"Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy","volume":"86","author":"Tyska","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2016.08.079_bib53","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0735-1097(02)03009-7","article-title":"Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy","volume":"41","author":"Crilley","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib54","doi-asserted-by":"crossref","first-page":"12607","DOI":"10.1073\/pnas.1309493110","article-title":"Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human \u03b2-cardiac myosin motor function","volume":"110","author":"Sommese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2016.08.079_bib55","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1074\/jbc.M113.511204","article-title":"The hypertrophic cardiomyopathy myosin mutation R453C alters ATP binding and hydrolysis of human cardiac \u03b2-myosin","volume":"289","author":"Bloemink","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2016.08.079_bib56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/cvr\/cvu127","article-title":"Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations","volume":"103","author":"Witjas-Paalberends","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2016.08.079_bib57","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1172\/JCI116957","article-title":"Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy","volume":"93","author":"Anan","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2016.08.079_bib58","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF02281865","article-title":"Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg-->Cys mutation in the beta-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure","volume":"97","author":"Ko","year":"1996","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<385::AID-HUMU4>3.0.CO;2-E","article-title":"Genotype-phenotype analysis in four families with mutations in \u03b2-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy","volume":"12","author":"Tesson","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacc.2016.08.079_bib60","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM199804303381802","article-title":"Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy","volume":"338","author":"Niimura","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib61","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCGENETICS.111.960831","article-title":"Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome","volume":"5","author":"Page","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib62","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCRESAHA.110.223834","article-title":"Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history","volume":"108","author":"Seidman","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2016.08.079_bib63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ng.309","article-title":"A\u00a0common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia","volume":"41","author":"Dhandapany","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib64","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/CIRCULATIONAHA.114.011207","article-title":"Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation","volume":"130","author":"Adalsteinsdottir","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib65","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.2009.371","article-title":"Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy","volume":"301","author":"Maron","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2016.08.079_bib66","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib67","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.CIR.0000139847.74101.03","article-title":"Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy","volume":"110","author":"Chimenti","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib68","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","article-title":"Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy","volume":"50","author":"Monserrat","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase A replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib71","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13023-015-0338-2","article-title":"Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years' treatment","volume":"10","author":"Kampmann","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jacc.2016.08.079_bib72","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.jacc.2007.02.061","article-title":"Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype","volume":"49","author":"Kubo","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib73","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/hrt.2007.134684","article-title":"Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes","volume":"94","author":"Kaski","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2016.08.079_bib74","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1399-0004.2008.01062.x","article-title":"Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology","volume":"74","author":"Menon","year":"2008","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib75","doi-asserted-by":"crossref","first-page":"e001879","DOI":"10.1161\/JAHA.115.001879","article-title":"Novel phenotype-genotype correlations of restrictive cardiomyopathy with myosin-binding protein C (MYBPC3) gene mutations tested by next-generation sequencing","volume":"4","author":"Wu","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2016.08.079_bib76","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1034\/j.1399-0004.2001.590406.x","article-title":"Clinical and molecular studies of a large family with desmin-associated restrictive cardiomyopathy","volume":"59","author":"Zhang","year":"2001","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib77","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/hmg\/dds022","article-title":"Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations","volume":"21","author":"Purevjav","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib78","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/cvr\/cvm015","article-title":"Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy","volume":"77","author":"Duboscq-Bidot","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2016.08.079_bib79","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ijcard.2010.08.004","article-title":"Analysis of the Z-disc genes PDLIM3 and MYPN in patients with hypertrophic cardiomyopathy","volume":"145","author":"Bagnall","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI200316336","article-title":"Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations","volume":"111","author":"Mogensen","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2016.08.079_bib81","doi-asserted-by":"crossref","first-page":"H2604","DOI":"10.1152\/ajpheart.91506.2007","article-title":"Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI","volume":"294","author":"Du","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib82","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1016\/j.jacc.2014.09.071","article-title":"Disturbance in Z-disk mechanosensitive proteins induced by a persistent mutant myopalladin causes familial restrictive cardiomyopathy","volume":"64","author":"Huby","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib83","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0735-1097(94)90740-4","article-title":"The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients","volume":"23","author":"Kasper","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib84","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.CIR.80.3.564","article-title":"Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975\u20131984","volume":"80","author":"Codd","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib85","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib86","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng815","article-title":"Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy","volume":"30","author":"Gerull","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib87","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/CIRCGENETICS.111.000062","article-title":"Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy","volume":"6","author":"Norton","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib88","doi-asserted-by":"crossref","first-page":"270ra6","DOI":"10.1126\/scitranslmed.3010134","article-title":"Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease","volume":"7","author":"Roberts","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib89","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.aaa5458","article-title":"Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy","volume":"349","author":"Hinson","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jacc.2016.08.079_bib90","unstructured":"Locus Reference Genomic. 2011. Available at: http:\/\/www.lrg-sequence.org. Accessed October 17,\u00a02016."},{"key":"10.1016\/j.jacc.2016.08.079_bib91","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1172\/JCI74523","article-title":"RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing","volume":"124","author":"Maatz","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2016.08.079_bib92","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nm.2693","article-title":"RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing","volume":"18","author":"Guo","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib93","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jacc.2009.05.038","article-title":"Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy","volume":"54","author":"Brauch","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib94","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1752-8062.2010.00198.x","article-title":"Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy","volume":"3","author":"Li","year":"2010","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jacc.2016.08.079_bib95","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/j.ejmg.2011.07.005","article-title":"Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy","volume":"54","author":"Millat","year":"2011","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib96","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/CIRCGENETICS.113.000011","article-title":"Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy","volume":"6","author":"Wells","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib97","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1081578","article-title":"Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban","volume":"299","author":"Schmitt","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jacc.2016.08.079_bib98","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1172\/JCI17892","article-title":"Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human","volume":"111","author":"Haghighi","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2016.08.079_bib99","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1073\/pnas.0510519103","article-title":"A\u00a0mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy","volume":"103","author":"Haghighi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2016.08.079_bib100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12881-015-0167-0","article-title":"A\u00a0study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations","volume":"16","author":"Truszkowska","year":"2015","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib101","doi-asserted-by":"crossref","first-page":"22235","DOI":"10.1038\/srep22235","article-title":"Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies","volume":"6","author":"Fish","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2016.08.079_bib102","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1073\/pnas.1013987108","article-title":"Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A","volume":"108","author":"Ha","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2016.08.079_bib103","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1074\/jbc.M114.630319","article-title":"Acute inotropic and lusitropic effects of cardiomyopathic R9C mutation of phospholamban","volume":"290","author":"Abrol","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2016.08.079_bib104","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jacc.2006.07.016","article-title":"Phospholamban R14 deletion results in late-onset, mild, hereditary dilated cardiomyopathy","volume":"48","author":"DeWitt","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib105","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","article-title":"Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy","volume":"14","author":"van der Zwaag","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2016.08.079_bib106","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI118445","article-title":"Mapping a cardiomyopathy locus to chromosome 3p22-p25","volume":"97","author":"Olson","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2016.08.079_bib107","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1161\/01.CIR.0000144458.58660.BB","article-title":"SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia","volume":"110","author":"McNair","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib108","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jama.293.4.447","article-title":"Sodium channel mutations and susceptibility to heart failure and atrial fibrillation","volume":"293","author":"Olson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2016.08.079_bib109","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2010.09.084","article-title":"SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism","volume":"57","author":"McNair","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/32675","article-title":"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation","volume":"392","author":"Chen","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2016.08.079_bib111","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCEP.111.963983","article-title":"Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization","volume":"4","author":"Watanabe","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib112","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.hrthm.2007.09.015","article-title":"Cardiac sodium channel mutation in atrial fibrillation","volume":"5","author":"Ellinor","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2016.08.079_bib113","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1172\/JCI62862","article-title":"Genetic mutations and mechanisms in dilated cardiomyopathy","volume":"123","author":"McNally","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2016.08.079_bib114","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","article-title":"Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease","volume":"341","author":"Fatkin","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib115","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0735-1097(02)02954-6","article-title":"Natural history of dilated cardiomyopathy due to lamin A\/C gene mutations","volume":"41","author":"Taylor","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib116","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI200419448","article-title":"Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A\/C-deficient mice","volume":"113","author":"Nikolova","year":"2004","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2016.08.079_bib117","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib118","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib119","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMc052632","article-title":"Primary prevention of sudden death in patients with lamin A\/C gene mutations","volume":"354","author":"Meune","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib120","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.hrthm.2013.06.020","article-title":"Implantable cardioverter-defibrillators in lamin A\/C mutation carriers with cardiac conduction disorders","volume":"10","author":"Anselme","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2016.08.079_bib121","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jacc.2014.08.030","article-title":"Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases?","volume":"64","author":"Arbustini","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib122","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacc.2015.06.017","article-title":"Isolated noncompaction of the left ventricle in adults","volume":"66","author":"Hussein","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib123","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2013.01.073","article-title":"Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians","volume":"61","author":"Marcus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib124","first-page":"385","article-title":"Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management","volume":"40","author":"Meyers","year":"2013","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.jacc.2016.08.079_bib125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/HCO.0b013e32832a1d2e","article-title":"Restrictive cardiomyopathy","volume":"24","author":"Mogensen","year":"2009","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib126","unstructured":"GeneTests. 2016. Available at: https:\/\/www.genetests.org. Accessed October 17,\u00a02016."},{"key":"10.1016\/j.jacc.2016.08.079_bib127","unstructured":"GTR: Genetic Testing Registry. National Institutes of Health. Available at: https:\/\/www.ncbi.nlm.nih.gov\/gtr\/. Accessed August 1, 2016."},{"key":"10.1016\/j.jacc.2016.08.079_bib128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/CIRCHEARTFAILURE.108.817346","article-title":"Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"2","author":"Hershberger","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2016.08.079_bib129","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2015.09.033","volume":"66","author":"Levine","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib130","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2015.09.034","volume":"66","author":"Maron","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib131","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.jacc.2015.09.035","volume":"66","author":"Maron","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib132","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/HCO.0000000000000049","article-title":"Human-induced pluripotent stem cell models of inherited cardiomyopathies","volume":"29","author":"Karakikes","year":"2014","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jacc.2016.08.079_bib133","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/CIRCRESAHA.114.304383","article-title":"Two strikes and you're out: gene-gene mutation interactions in HCM","volume":"115","author":"Dorn","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2016.08.079_bib134","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.08.079_bib135","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCGENETICS.112.962761","article-title":"Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy","volume":"5","author":"Lakdawala","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib136","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCGENETICS.113.000037","article-title":"Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy","volume":"6","author":"Valente","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2016.08.079_bib137","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","article-title":"Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy","volume":"103","author":"Lim","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.08.079_bib138","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1172\/JCI42028","article-title":"Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-\u03b2","volume":"120","author":"Teekakirikul","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2016.08.079_bib139","first-page":"480","article-title":"Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy","volume":"1","author":"Shimada","year":"2013","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2016.08.079_bib140","first-page":"180","article-title":"Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression","volume":"3","author":"Ho","year":"2015","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2016.08.079_bib141","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-8587(14)70241-4","article-title":"Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial","volume":"3","author":"Axelsson","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2016.08.079_bib142","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.1236921","article-title":"Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy","volume":"342","author":"Jiang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jacc.2016.08.079_bib143","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardfail.2009.01.006","article-title":"Genetic evaluation of cardiomyopathy\u2014a Heart Failure Society of America Practice Guideline","volume":"15","author":"Hershberger","year":"2009","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2016.08.079_bib144","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716368231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109716368231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T16:17:09Z","timestamp":1658161029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109716368231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":144,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0735109716368231"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2016.08.079","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Mechanistic Insights Into the\u00a0Genetics of Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2016.08.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}